Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+13.64%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$59.3B
AUM Growth
+$5.38B
(+10%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
30.78%
Holding
971
New
135
Increased
326
Reduced
323
Closed
128
Top Buys
| 1 |
Capital One
COF
|
$120M |
| 2 |
CSX Corp
CSX
|
$120M |
| 3 |
Amazon
AMZN
|
$120M |
| 4 |
Johnson Controls International
JCI
|
$114M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$108M |
Top Sells
| 1 |
3M
MMM
|
$169M |
| 2 |
DFS
Discover Financial Services
DFS
|
$163M |
| 3 |
WESCO International
WCC
|
$144M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$139M |
| 5 |
Royal Caribbean
RCL
|
$130M |
Sector Composition
| 1 | Technology | 29.16% |
| 2 | Healthcare | 13.82% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 9.51% |
| 5 | Industrials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Biomea Fusion
BMEA
$109M
| $900K | ﹤0.01% |
500,000
| – | – |
|
802
Surrozen
SRZN
$107M
| $793K | ﹤0.01% |
88,653
| – | – |
|
803
Palladyne AI
PDYN
$294M
| $722K | ﹤0.01% |
83,333
| – | – |
|
804
Halliburton
HAL
$19.2B
| $638K | ﹤0.01% |
+31,310
| New | +$638K |
|
805
Veru
VERU
$48.3M
| $582K | ﹤0.01% |
100,000
| – | – |
|
806
ResMed
RMD
$40.1B
| $542K | ﹤0.01% |
2,099
-22,564
| -91% | -$5.82M |
|
807
Kosmos Energy
KOS
$823M
| $516K | ﹤0.01% |
300,000
-3,390,000
| -92% | -$5.83M |
|
808
Traws Pharma
TRAW
$11.8M
| $488K | ﹤0.01% |
330,000
| – | – |
|
809
Tenax Therapeutics
TENX
$27.4M
| $480K | ﹤0.01% |
83,333
| – | – |
|
810
Paymentus
PAY
$4.64B
| $478K | ﹤0.01% |
14,588
-75,000
| -84% | -$2.46M |
|
811
Lifezone Metals Limited Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
LZM.WS
$31.8M
| $477K | ﹤0.01% |
1,231,797
| – | – |
|
812
Liberty Energy
LBRT
$1.74B
| $459K | ﹤0.01% |
40,000
-40,000
| -50% | -$459K |
|
813
BP
BP
$88.4B
| $449K | ﹤0.01% |
15,000
-620,000
| -98% | -$18.6M |
|
814
M&T Bank
MTB
$31.6B
| $389K | ﹤0.01% |
2,007
-44,961
| -96% | -$8.72M |
|
815
Ovid Therapeutics
OVID
$91.7M
| $379K | ﹤0.01% |
1,150,000
| – | – |
|
816
Applied Therapeutics
APLT
$67M
| $377K | ﹤0.01% |
1,211,629
-750,000
| -38% | -$233K |
|
817
Patterson-UTI
PTEN
$2.25B
| $356K | ﹤0.01% |
60,000
| – | – |
|
|
SHMD
818
SCHMID Group
SHMD
$104M
| $346K | ﹤0.01% |
125,000
| – | – |
|
|
NUAI
819
New Era Energy & Digital, Inc. Common Stock
NUAI
$10.5M
| $344K | ﹤0.01% |
+700,000
| New | +$344K |
|
820
GSK
GSK
$79.8B
| $344K | ﹤0.01% |
+8,967
| New | +$344K |
|
821
C4 Therapeutics
CCCC
$190M
| $286K | ﹤0.01% |
200,000
-1,350,000
| -87% | -$1.93M |
|
822
OPAL Fuels
OPAL
$64.4M
| $278K | ﹤0.01% |
115,000
| – | – |
|
823
AMN Healthcare
AMN
$775M
| $267K | ﹤0.01% |
+12,939
| New | +$267K |
|
|
ETHMW
824
Dynamix Corporation Warrant
ETHMW
$18.6M
| $263K | ﹤0.01% |
675,000
| – | – |
|
825
InflaRx
IFRX
$106M
| $262K | ﹤0.01% |
+331,113
| New | +$262K |
|